Mumbai, Sept. 29 -- The total value of the contract stands at AED 13.5 million, which translates to approximately Rs 32.63 crore at prevailing exchange rates. The sub-contract entails the performance... Read More
Mumbai, Sept. 29 -- Global markets face a pivotal week led by the US employment report, which will be closely tracked alongside ADP payrolls, JOLTS openings, Challenger job cuts, and ISM surveys, whil... Read More
Mumbai, Sept. 29 -- The scrip was listed at Rs 858.10, exhibiting a premium of 13.81% to the issue price. So far, the stock has hit a high of Rs 863.70 and a low of Rs 806. On the BSE, over 5.16 lakh... Read More
Mumbai, Sept. 29 -- The Dow advanced 299.97 points (0.7%) to 46,247.29, the S&P 500 climbed 38.98 points (0.6%) to 6,643.70 and the Nasdaq rose 99.37 points (0.4%) to 22,484.07. The Commerce Departme... Read More
Mumbai, Sept. 29 -- The appointment follows the untimely and sudden demis of Late Vimal Jain, CFO of AU Small Finance Bank on 10 September 2025. Gaurav Jain, a rank holder Chartered Accountant and MB... Read More
Mumbai, Sept. 29 -- The scrip was listed at Rs 295, at an 8.39% discount to the issue price. So far, the stock has hit a high of Rs 305.85 and a low of Rs 294.80. On the BSE, over 1.46 lakh shares of... Read More
Mumbai, Sept. 29 -- Radico Khaitan has unveiled the final two editions of its award-winning Rampur Jugalbandi series, Rampur Jugalbandi #7 and #8, at the TFWA World Exhibition in Cannes 2025. With thi... Read More
Mumbai, Sept. 29 -- Nazara Technologies has allotted 18,52,32,512 equity shares under bonus issue in ratio of 1:1 on 29 September 2025. Post allotment, the paid up equity share capital has increased t... Read More
Mumbai, Sept. 29 -- SEPC has received a work order from Avenir International Engineers and Consultants LLC, Abu Dhabi for the provision of engineering services for various ADNOC projects for a total ... Read More
Mumbai, Sept. 29 -- Miqnaf, a proprietary antibiotic discovered and developed by Wockhardt, is the third novel drug from the company's in-house discovery programme. It is intended for the treatment of... Read More